Cardiology expert, Christian Ruff, MD, MPH & primary care specialist, Elaine Hylek, MD, MPH will review the latest research and recommendations for patients with polyvascular disease. The faculty also will discuss patient cases that cover long-term atherothrombotic risks, chronic coronary artery disease (CAD)/peripheral artery disease (PAD), benefits of direct oral anticoagulants (DOACs), and considerations for the multidisciplinary team.
After implementing current guideline-directed medical management, there is still urgency to address residual cardiovascular risk. Among the drivers of residual cardiovascular risk, inflammation has generated considerable interest, first based on preclinical and biomarker studies in humans. More recently, translation has inspired clinical trials in this domain. This presentation will consider inflammation as a process that links traditional and nontraditional risk factors to atherothrombotic events.